Document is current
Any future updates will be listed below
-
Authors
Tran, Nathan L. https://orcid.org/0000-0002-7917-3945
Jiang, Jiewei https://orcid.org/0000-0001-5497-9371
Ma, Min https://orcid.org/0000-0002-3529-0330
Gadbois, Gillian E.
Gulay, Kevin C. M.
Verano, Alyssa L. https://orcid.org/0000-0003-2478-202X
Schiavon, Cara R.
Rebollo, Elena
Zhou, Haowen
Huang, Chun-Teng
Murad, Rabi
Scott, David A. https://orcid.org/0000-0002-8668-2449
Manor, Uri
Bang, Anne G.
Tiriac, Herve
Lowy, Andrew M.
Wang, Eric S. https://orcid.org/0000-0002-6250-9748
Ferguson, Fleur M. https://orcid.org/0000-0003-4091-7617
- License Information
-
More Information
Article History
Received: 16 May 2024
Accepted: 30 June 2025
First Online: 11 August 2025
Competing interests
: F.M.F., E.S.W., J.J. and N.L.T. are inventors on a patent application related to this work (US 63/515,472). The E.S.W. lab receives or has received research resources in kind from SK Life Sciences. F.M.F. is a scientific cofounder and equity holder in Proximity Therapeutics and was previously a scientific advisory board member of Triana Biomedicines. F.M.F. is or was recently a consultant or received speaking honoraria from RA Capital, Tocris BioTechne, Eli Lilly, Amgen, Neomorph and Plexium. The F.M.F. lab receives or has received research funding, travel funding or resources in kind from Ono Pharmaceutical, Eli Lilly, Promega and Merck. F.M.F.’s interests have been reviewed and approved by UCSD in accordance with its conflict-of-interest policies. The remaining authors declare no competing interests.
